Table 2.
Adduct levels in hepatic DNA of rats treated with NPYRa
Dose (mg/kg bw) | 7,8-Butanoguanine 6 (μmol/mol Gua) | Adduct 9 |
N2-(4-HOB)dGuo (18)b (μmol/mol dGuo) | N6-(4-HOB)dAdo (19)b (μmol/mol dAdo) | O2-(4-HOB)dThd (20)b (μmol/mol dThd) | ||
---|---|---|---|---|---|---|---|
(6S,8S)-(μmol/mol dGuo) | (6R,8R)-(μmol/mol dGuo) | Total (μmol/mol dGuo) | |||||
46 | 952 ± 180 | 0.154 ± 0.057 | 0.077 ± 0.021 | 0.231 ± 0.078 | 0.369 ± 0.134c | 0.013 ± 0.006 | 1.065 ± 0.349 |
92 | 1742 ± 245 | 0.341 ± 0.066 | 0.158 ± 0.026 | 0.499 ± 0.091 | 0.478 ± 0.114c | 0.008 ± 0.004 | 2.049 ± 0.361 |
184 | 3032 ± 855 | 0.634 ± 0.188 | 0.271 ± 0.054 | 0.905 ± 0.240 | 0.951 ± 0.193c | 0.016 ± 0.008 | 3.767 ± 0.840 |
Rats were given a single dose of NPYR by gavage and sacrificed 16 h later. Limits of quantitation were: 6, 0.1 μmol/mol Gua; 9, 0.004 μmol/mol dGuo; 18, 0.02 μmol/mol dGuo; 19, 0.002 μmol/mol dAdo; 20, 0.01 μmol/mol dThd.
DNA was treated with NaBH3CN during enzyme hydrolysis to convert adducts 13–15 to 18–20.
Control amount was subtracted from each value.